Release Date: 02/11/20 09:21 Summary: CSR Limited Review of Results - half year ended 30 Sept 2020 Price Sensitive: Yes Download Document 718.43KB Download
PTX This rare type of lymphoma ruins the body – so do existing treatments. Prescient could have a solution